Evidence map›Paper›PMID 40922750›Full record

ArticleAdvanced pharmaceutical bulletin2025

The Impact Beyond Academia: Patent Citations of the Advanced Pharmaceutical Bulletin.

Mihály Hegedűs, Mehdi Dadkhah, Lóránt Dénes Dávid

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced pharmaceutical bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mihály HegedűsDepartment of Finance and Accounting, Tomori Pál College, Budapest, Hungary.ORCID https://orcid.org/0000-0001-8064-0208
Mehdi DadkhahDepartment of Sustainable Tourism, Institute of Rural Development and Sustainable Economy, Hungarian University of Agriculture and Life Sciences (MATE), Gödöllő, Hungary.ORCID https://orcid.org/0000-0001-7964-4762
Lóránt Dénes DávidDepartment of Tourism and Hospitality, Faculty of Economics and Business, John Von Neumann University, Kecskemét, Hungary.ORCID https://orcid.org/0000-0001-7880-9860

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aims to analyze the technological impact of papers that Methods: Current research uses a Scientometric approach to analyze patent citations to published papers by the APB. The Lens has been used for collecting patents that cited related papers. Some of the data analysis was conducted using the Lens analytical tool. Results: Results show that APB's patent-to-paper citation rate is 32.39%, above the toxicology field average (6.15%) but below pharmacology (46.33%), indicating significant technological influence. APB contributes to both science and technology, attracting global inventors. Conclusion: The patent citations metric can be used to understand how a journal contributes to technological progress. However, these methods need to be standardized and promoted to understand a journal's real value in technology contribution.

Indexed as

Advanced Pharmaceutical BulletinCircular economyPatentPatent to papers citationsSustainable development goalsTechnological impact

Identifiers

PMID40922750
PMCPMC12413965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.